Golden State Equity Partners Orchard Therapeutics PLC Transaction History

Golden State Equity Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 01, 2023	SELL	$0.44 - $5.38 $9,922 - $121,319	-22,550 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$0.7 - $1.51 $15,784 - $34,050	22,550 New	22,550 $16,000
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $15,014 - $32,389	-21,450 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.16 - $2.23 $24,882 - $47,833	21,450 New	21,450 $28,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

Stay updated on Golden State Equity Partners with notifications on news.